Aditxt Inc. Announces 1-for-113 Reverse Stock Split to Regain Nasdaq Compliance
October 30th, 2025 1:25 PM
By: Newsworthy Staff
Aditxt Inc. is implementing a 1-for-113 reverse stock split effective November 3, 2025, to meet Nasdaq's minimum bid price requirement following shareholder approval.

Aditxt Inc. (NASDAQ: ADTX) will implement a 1-for-113 reverse stock split of its common stock effective at the opening of trading on November 3, 2025. The company's stock will continue trading under the symbol ADTX on the Nasdaq exchange. This corporate action, which received stockholder approval on September 23, 2025, represents a significant restructuring of the company's share structure aimed at addressing regulatory compliance requirements.
Following the reverse stock split implementation, every 113 shares of issued and outstanding common stock will convert into one share of common stock. The company has specified that fractional shares resulting from the consolidation will be rounded up to the nearest whole share. This approach ensures that shareholders maintain their proportional ownership in the company while simplifying the share structure. The primary objective behind this strategic move is to help Aditxt regain compliance with Nasdaq's minimum bid price requirement, which mandates that listed companies maintain a minimum closing bid price of $1.00 per share.
The reverse stock split represents a critical step for Aditxt in maintaining its Nasdaq listing status, as failure to meet exchange requirements could result in delisting proceedings. Nasdaq compliance is essential for public companies as it provides continued access to public markets, maintains investor confidence, and ensures liquidity for shareholders. The company's decision to pursue this corporate action follows the stockholder approval obtained during the September meeting, demonstrating shareholder support for management's strategy to address regulatory concerns.
Aditxt operates as a social innovation platform focused on accelerating promising health innovations across multiple therapeutic areas. The company's current programs target autoimmunity, cancer and early disease detection, infectious diseases, and women's health. Additional information about the company and its latest developments is available through its corporate communications channels, including the company's newsroom at https://ibn.fm/ADTX. The full details of the reverse stock split announcement can be accessed in the official press release available at https://ibn.fm/KgRGL.
This corporate action represents a significant milestone in Aditxt's ongoing efforts to strengthen its market position and maintain compliance with exchange requirements. The reverse stock split will reduce the total number of outstanding shares while proportionally increasing the share price, potentially making the stock more attractive to institutional investors and meeting Nasdaq's minimum price threshold. The timing of the implementation, set for November 3, 2025, provides adequate notice to shareholders and market participants to adjust to the new share structure.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
